University of East Anglia scientists have developed cutting-edge MRI technology to diagnose a common heart problem more ...

The FDA approved Edwards Lifesciences Corp.'s Sapien 3 platform for patients with asymptomatic severe aortic stenosis.

Recent research from Karl Landsteiner University of Health Sciences (KL Krems) provides important new insights into how aortic valve size is associated with the degree of valve calcification in ...

As the degree of stenosis becomes worse ... Since this percentage increases substantially in aortic stenosis, the loss of the atrial kick with atrial fibrillation can significantly compromise ...

Doctors at New York-Presbyterian performed an extremely rare surgery on Hend Almesafri, 10, John Catoliato, 2, and Teddy Carter, 3, changing their lives forever.

Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS ...

Humans have long used saunas and cold plunges for sleep and other health benefits — but it's not for everyone. Here are the ...

The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve ...

The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.

Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.